1
(Adds details in paragraphs 5 to 12, analyst's comment in paragraph 9) By Siddhi Mahatole and Kunal Das Nov 18 (Reuters) – The US Food and Drug Administration has approved Regeneron Pharmaceuticals'
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)